Загрузка...
Effects of Telmisartan and Candesartan on the Metabolism of Lipids and Glucose in Kidney Transplant Patients: A Prospective, Randomized Crossover Study
BACKGROUND: The risk of cardiovascular events remains after kidney transplantation (KT). Abnormal glucose metabolism and hyperlipidemia contribute partly to this risk. Among angiotensin II type-1 receptor blockers, telmisartan alone has been shown to ameliorate these effects on glucose and lipid met...
Сохранить в:
| Опубликовано в: : | Transplant Direct |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415969/ https://ncbi.nlm.nih.gov/pubmed/30882027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000861 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|